Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review

Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review

Anti-Mullerian hormone is a robust marker of ovarian reserve and ovarian response in in vitro fertilisation (IVF). However, its role extends beyond improving the safety of IVF by aiding in choosing appropriate protocols and dosing. This review looks at the value of pre-treatment anti-Mullerian hormo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Duru Shah, Padma Rekha Jirge
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-01-01
Series:	Journal of Human Reproductive Sciences
Subjects:	anti-mullerian hormone clinical utility of anti-mullerian hormone in vitro fertilisation ovulation induction polycystic ovary syndrome
Online Access:	https://journals.lww.com/10.4103/jhrs.jhrs_153_23
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Is There a Relationship between Serum Anti-Mullerian Hormone Levels and Abortion Rates in Patients Who Received In vitro Fertilisation-Embryo Transfer Cycles?
by: Pinar Karacin, et al.
Published: (2023-01-01)

Correlation of Anti-Müllerian Hormone with Polycystic Ovarian Disease and its Relation with Age
by: Sara Omer Muhammed, et al.
Published: (2019-08-01)

High anti-Müllerian hormone level as a predictor of poor pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection: a retrospective cohort study
by: Fei Zhao, et al.
Published: (2025-01-01)

Comparing Assisted Reproductive Outcomes in Women with Different Polycystic Ovary Syndrome Phenotypes Undergoing Frozen Embryo Transfer
by: Anubhuti Patel, et al.
Published: (2023-10-01)

Age and serum anti-Müllerian hormone levels as predictors of time to return of menses after chemotherapy
by: Madhavi-Priya Singh, et al.
Published: (2025-01-01)

The effect of anti mullerian hormone and follicle stimulating hormone discordance on oocyte quality and live birth rates
by: Seray Kaya, et al.
Published: (2024-04-01)

Geographical Diversity in the Age Specific Anti Müllerian Hormone Levels in Infertile Women: A Hospital Based Cohort Study
by: Mir Jaffar, et al.
Published: (2023-01-01)

Mastalgia Assesment and Hormonal Correlations in Patients with Polycystic Ovary Syndrome
by: Emel Kıyak Çağlayan, et al.
Published: (2015-04-01)

Co-occurrence of a Mullerian anomaly and Kallmann syndrome: A case report
by: Lea C. George, et al.
Published: (2025-03-01)

Ovulation Induction Techniques in Polycystic Ovary Syndrome - Systematic Review
by: Daria Michałka, et al.
Published: (2025-01-01)

Impact of Dienogest Alone or in Combination with Ethinylestradiol on the Quality of Life of Women with Endometriosis: A Prospective Cohort Study
by: Mujde Canday, et al.
Published: (2023-12-01)

Hormonal contraception in women with polycystic ovary syndrome: Contraceptive and non-contraceptive effects. A clinical lecture
by: Olga A. Pustotina
Published: (2024-12-01)

Analysis of the Effect of Female Genital Tuberculosis on Ovarian Reserve Parameters
by: Sharma Richa, et al.
Published: (2023-04-01)

Factors Influencing the Pregnancy Outcome of Intrauterine Insemination and Follow-Up Treatment
by: Xuan Huang, et al.
Published: (2023-01-01)

Therapeutic role of isoflavones from traditional medicine in the management of polycystic ovary syndrome
by: Ashwini Armarkar, et al.
Published: (2025-03-01)

Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential
by: Jingyi Yuan, et al.
Published: (2025-02-01)

Factors Associated with Poor Ovarian Reserve in Young Infertile Women: A Hospital-based Cohort Study
by: Sanghamitra Hazarika, et al.
Published: (2023-04-01)

Role of Inhibin B and Ratio of Luteinizing: Follicle-Stimulating Hormones in Phenotyping Polycystic Ovarian Syndrome
by: Zainab G. Falh, et al.
Published: (2024-12-01)

Relation of Follicular Fluid Soluble Receptor for Advanced Glycation End-Products Concentration and Anti Mullerian Hormone in Polycystic Ovary Syndrome and Non-PCOS Women Referring to In Vitro Fertilization Center: Case-Control Study
by: Neda Emami, et al.
Published: (2025-01-01)

Success Rates of Clomiphene Citrate and Recombinant Gonadotropin Cycles: A Single-Center Experience
by: Beril Gurlek, et al.
Published: (2020-03-01)

Impact of headache in women with polycystic ovary syndrome
by: Lina Zabulienë, et al.
Published: (2021-12-01)

The association between melatonin hormone and reproductive hormones in polycystic ovary syndrome: A case–control study
by: Ban Jabir Edan, et al.
Published: (2024-01-01)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
by: Sweekruti Jena, et al.
Published: (2023-04-01)

Quality of Life in The Community of Women with Polycystic Ovary Syndrome (PCOS): A Phenomenology Study
by: Neina Qonita Istiqomah, et al.
Published: (2023-12-01)

Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01)

Identification of molecular characteristics in polycystic ovary syndrome using single-cell and transcriptome analysis
by: Xiaolin Zhu, et al.
Published: (2025-01-01)

Perceived Effects and Prevention of Polycystic Ovary Syndrome among Women Living in Ilorin-South LGA, Kwara State, Nigeria
by: Abdulqudus Tosin Jamiu, et al.
Published: (2024-12-01)

Animal experiments and network pharmacology to explore the anti-inflammatory mechanism of dapagliflozin in the treatment of polycystic ovary syndrome
by: Yong Liu, et al.
Published: (2025-12-01)

Clomiphene Citrate versus Clomiphene Citrate in combination with other drugs in Ovulation Induction in Patients with Polycystic Ovary Syndrome
by: Mostafa Khodary, et al.
Published: (2025-07-01)

Ocular Surface Disease Severity in Polycystic Ovary Syndrome: is This Really Significant in Daily Life?
by: Demet Yabanoglu, et al.
Published: (2022-03-01)

The role of salivary antioxidant level in polycystic ovary syndrome women under assisted reproductive technology treatment: A case-control study
by: Narges Gholizadeh, et al.
Published: (2025-02-01)

The role of immunity in insulin resistance in patients with polycystic ovary syndrome
by: Qixuan Zhang, et al.
Published: (2025-01-01)

Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome
by: WANG Xueling, et al.
Published: (2025-02-01)

Effects of non-pharmacological interventions on biochemical hyperandrogenism in women with polycystic ovary syndrome: a systematic review and network meta-analysis
by: Qi Jin, et al.
Published: (2025-01-01)

Closer look at circulating nitric oxide levels and their association with polycystic ovary syndrome: A meta-analytical exploration
by: Seyed Sobhan Bahreiny, et al.
Published: (2025-02-01)

Maternal and Perinatal Outcomes in Women with Polycystic Ovary Syndrome Undergoing Artificial Frozen-Thawed Embryo Transfer Cycles: A Retrospective Study
by: Saeideh Dashti, et al.
Published: (2025-01-01)

Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
by: Paola Quaresima, et al.
Published: (2025-01-01)

Improving Fertility Treatment Documentation – A Survey
by: Aby Kottal Koshy
Published: (2023-04-01)

Serum microRNAs as Diagnostic Markers in Polycystic Ovary Syndrome: A Narrative Review
by: K Lavanya, et al.
Published: (2025-01-01)

Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome
by: Armaiti Parvez Mody, et al.
Published: (2025-01-01)